TNF Pharmaceuticals, Inc.
TNFA
$0.146
$0.0096.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.50% | -483.98% | -339.60% | -34.82% | 2.37% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 619.16% | 256.18% | 261.63% | 1,938.61% | -225.69% |
| Change in Net Operating Assets | -156.38% | -193.42% | 1,611.11% | 463.91% | 408.87% |
| Cash from Operations | 9.86% | 32.04% | 24.87% | 33.12% | 22.41% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -130.99% | -430.56% | 9.42% | 85.86% | 288.19% |
| Cash from Investing | -130.99% | -430.56% | 9.42% | 85.86% | 288.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -4.67% | -4.67% | -4.67% | -100.00% |
| Repurchase of Preferred Stock | 100.00% | 17.97% | -- | -- | -- |
| Total Dividends Paid | 50.50% | -82.17% | -- | -- | -- |
| Other Financing Activities | 146.90% | 100.00% | -- | -- | -- |
| Cash from Financing | 554.07% | -4.99% | -17.25% | -45.88% | -115.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -510.78% | -229.81% | 7,873.91% | 143.29% | 103.71% |